These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 39182508

  • 1. Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study.
    Rocca J, Beydon M, Le Guern V, Hachulla E, Couderc M, Jousse-Joulin S, Devauchelle-Pensec V, Gottenberg JE, Vittecoq O, Lavigne C, Schmidt J, Larroche C, Mariette X, Seror R, Nocturne G.
    Lancet Rheumatol; 2024 Oct; 6(10):e703-e712. PubMed ID: 39182508
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).
    Jackson AE, Mian M, Kalpadakis C, Pangalis GA, Stathis A, Porro E, Conconi A, Cortelazzo S, Gaidano G, Lopez Guillermo A, Johnson PW, Martelli M, Martinelli G, Thieblemont C, McPhail ED, Copie-Bergman C, Pileri SA, Jack A, Campo E, Mazzucchelli L, Ristow K, Habermann TM, Cavalli F, Nowakowski GS, Zucca E.
    Oncologist; 2015 Oct; 20(10):1149-53. PubMed ID: 26268740
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
    Nguyen Y, Nocturne G, Henry J, Ng WF, Belkhir R, Desmoulins F, Bergé E, Morel J, Perdriger A, Dernis E, Devauchelle-Pensec V, Sène D, Dieudé P, Couderc M, Fauchais AL, Larroche C, Vittecoq O, Salliot C, Hachulla E, Le Guern V, Gottenberg JE, Mariette X, Seror R.
    Lancet Rheumatol; 2024 Apr; 6(4):e216-e225. PubMed ID: 38437852
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary MALT Lymphoma in Patients with Sjögren's Syndrome.
    Yachoui R, Leon C, Sitwala K, Kreidy M.
    Clin Med Res; 2017 Jun; 15(1-2):6-12. PubMed ID: 28487450
    [Abstract] [Full Text] [Related]

  • 8. [Progression of nodal marginal zone lymphoma into diffuse large B cell lymphoma in a patient with Sjögren's syndrome].
    Colović N, Terzić T, Radojković M, Palibrk V, Vidović A.
    Srp Arh Celok Lek; 2011 Jun; 139(3-4):229-32. PubMed ID: 21626771
    [Abstract] [Full Text] [Related]

  • 9. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.
    Voulgarelis M, Moutsopoulos HM.
    Rheum Dis Clin North Am; 2008 Nov; 34(4):921-33, viii. PubMed ID: 18984412
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature.
    Gorodetskiy VR, Probatova NA, Radenska-Lopovok SG, Ryzhikova NV, Sidorova YV, Sudarikov AB.
    Rheumatol Int; 2020 Mar; 40(3):499-506. PubMed ID: 31707561
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Active immunological profile is associated with systemic Sjögren's syndrome.
    Martel C, Gondran G, Launay D, Lalloué F, Palat S, Lambert M, Ly K, Loustaud-Ratti V, Bezanahary H, Hachulla E, Jauberteau MO, Vidal E, Hatron PY, Fauchais AL.
    J Clin Immunol; 2011 Oct; 31(5):840-7. PubMed ID: 21744183
    [Abstract] [Full Text] [Related]

  • 14. Mucosa-associated lymphoid tissue lymphomas in two patients with rheumatoid arthritis on second-line agents, and secondary Sjögren's syndrome.
    Sutcliffe N, Smith C, Speight PM, Isenberg DA.
    Rheumatology (Oxford); 2000 Feb; 39(2):185-8. PubMed ID: 10725070
    [Abstract] [Full Text] [Related]

  • 15. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
    Brito-Zerón P, Ramos-Casals M, EULAR-SS task force group.
    Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
    [Abstract] [Full Text] [Related]

  • 16. Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease.
    Raderer M, Püspök A, Stummvoll G, Längle F, Chott A.
    Scand J Gastroenterol; 2003 Mar; 38(3):294-7. PubMed ID: 12737445
    [Abstract] [Full Text] [Related]

  • 17. Clinical, histopathological and immunohistological study of lymphoid disorders in the parotid gland of patients with Sjögren's syndrome.
    Bozinović MT, Katić V, Krasić D, Veselinović D, Jovanović P, Krstić M.
    Vojnosanit Pregl; 2009 Dec; 66(12):955-60. PubMed ID: 20095514
    [Abstract] [Full Text] [Related]

  • 18. Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981-2021).
    Chatzis LG, Stergiou IE, Goules AV, Pezoulas V, Tsourouflis G, Fotiadis D, Tzioufas AG, Voulgarelis M.
    Rheumatology (Oxford); 2022 Aug 30; 61(9):3576-3585. PubMed ID: 34940812
    [Abstract] [Full Text] [Related]

  • 19. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.
    Voulgarelis M, Ziakas PD, Papageorgiou A, Baimpa E, Tzioufas AG, Moutsopoulos HM.
    Medicine (Baltimore); 2012 Jan 30; 91(1):1-9. PubMed ID: 22198497
    [Abstract] [Full Text] [Related]

  • 20. Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjögren's syndrome.
    Cassidy DT, McKelvie P, Harris GJ, Rose GE, McNab AA.
    Orbit; 2005 Dec 30; 24(4):257-63. PubMed ID: 16354635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.